Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus
Primary Purpose
Osteochondral Lesion of Talus
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Extracorporeal Shock Wave Therapy
Sponsored by
About this trial
This is an interventional supportive care trial for Osteochondral Lesion of Talus focused on measuring Extracorporeal Shock Wave Therapy, Osteochondral Lesions of Talus, Arthroscopy, Pain-relief
Eligibility Criteria
Inclusion Criteria:
For arthroscopy:
- Ankle pain, aggravated after exercise or weight-bearing activity, accompanied by lameness, joint stiffness and dysfunction for at least 3 months
- No talar collapse
- Talar cartilage injury cases before stage Ⅳ of Hepple classification
For shock wave therapy:
- Patients with micro-fractures treated with arthroscopic treatment of talar cartilage injury and were treated with routine rehabilitation training after arthroscopy
- Patients who till complained obvious ankle pain 3 months after surgery
Exclusion Criteria:
- Severe cardiovascular and cerebrovascular diseases
- Hemorrhagic diseases, coagulation disorders
- Bone immaturity
- Thrombosis
- Use of anti-immune agents
- Various types of tumor patients
- Pregnant women
- History of mental illness
- Patients who could not be followed
- Patients with other lower extremity injuries after surgery and were unwilling to participate in the study
Sites / Locations
- Southwest Hospital
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Extracorporeal Shock Wave Therapy
Arm Description
Extracorporeal Shock Wave Therapy to relieve pain after arthroscopy for osteochondral lesions of talus
Outcomes
Primary Outcome Measures
Change of VAS scores before and after shock wave therapy
The Visual Analogue Scale scores of the patients before and after the shock wave therapy are recorded. The scale ranges from 0-10 points, and decreases of the value represent a better outcome. The data analyses are performed with SPSS version 16.0 statistical software. Continuous variables are expressed as mean ± standard deviation, and 95% confidence intervals are determined. The data are compared by paired t test or rank-sum test. P value < 0.05 is considered as statistically significant.
Secondary Outcome Measures
Change of AOFAS scores before and after shock wave therapy
The American Orthopaedic Foot & Ankle Society scores of the patients before and after the shock wave therapy are recorded. The scale ranges from 0-100 points, and increases of the value represent a better outcome. The data analyses are performed with SPSS version 16.0 statistical software. Continuous variables are expressed as mean ± standard deviation, and 95% confidence intervals are determined. The data are compared by paired t test or rank-sum test. P value < 0.05 is considered as statistically significant.
Full Information
NCT ID
NCT03750253
First Posted
November 18, 2018
Last Updated
March 20, 2019
Sponsor
Southwest Hospital, China
1. Study Identification
Unique Protocol Identification Number
NCT03750253
Brief Title
Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus
Official Title
Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus
Study Type
Interventional
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2013 (Actual)
Primary Completion Date
February 1, 2019 (Actual)
Study Completion Date
July 1, 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Southwest Hospital, China
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Arthroscopic surgery is effective in treating osteochondral lesions of the talus. However, there are still some patients with postoperative ankle pain. This study aims to investigate the clinical efficacy of shock wave adjuvant therapy in the treatment of postoperative pain caused by cartilage injury of talus after arthroscopy and to provide basis for further popularization and application.
Detailed Description
Arthroscopic surgery is effective in treating osteochondral lesions of the talus. However, there are still some patients with postoperative ankle pain. This study was conducted to investigate the clinical efficacy of shock wave therapy in the treatment of postoperative pain caused by cartilage injury of talus after arthroscopy.
Patients with osteochondral lesions of the talus treated by arthroscopic microfracture surgery and still complained ankle pain three months after surgery were enrolled. Radial extracorporeal shock wave therapy was used to give energy to the injured region of the talus and the adjacent area.Treatment was done once a week for 5 consecutive weeks. After shock wave therapy,the patients were followed by Visual Analogue Scale (VAS), the American Orthopaedic Foot and Ankle Society ankle-hindfoot scale(AOFAS-AHFS) , and followed finally by Magnetic Resonance Imaging(MRI) of the ankle.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteochondral Lesion of Talus
Keywords
Extracorporeal Shock Wave Therapy, Osteochondral Lesions of Talus, Arthroscopy, Pain-relief
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Extracorporeal Shock Wave Therapy
Arm Type
Other
Arm Description
Extracorporeal Shock Wave Therapy to relieve pain after arthroscopy for osteochondral lesions of talus
Intervention Type
Other
Intervention Name(s)
Extracorporeal Shock Wave Therapy
Intervention Description
Extracorporeal Shock Wave Therapy will be used for pain-relief after arthroscopy for osteochondral lesions of the talus
Primary Outcome Measure Information:
Title
Change of VAS scores before and after shock wave therapy
Description
The Visual Analogue Scale scores of the patients before and after the shock wave therapy are recorded. The scale ranges from 0-10 points, and decreases of the value represent a better outcome. The data analyses are performed with SPSS version 16.0 statistical software. Continuous variables are expressed as mean ± standard deviation, and 95% confidence intervals are determined. The data are compared by paired t test or rank-sum test. P value < 0.05 is considered as statistically significant.
Time Frame
6 weeks, 12 weeks and last follow-up at an average of 2 years after shock wave therapy
Secondary Outcome Measure Information:
Title
Change of AOFAS scores before and after shock wave therapy
Description
The American Orthopaedic Foot & Ankle Society scores of the patients before and after the shock wave therapy are recorded. The scale ranges from 0-100 points, and increases of the value represent a better outcome. The data analyses are performed with SPSS version 16.0 statistical software. Continuous variables are expressed as mean ± standard deviation, and 95% confidence intervals are determined. The data are compared by paired t test or rank-sum test. P value < 0.05 is considered as statistically significant.
Time Frame
6 weeks, 12 weeks and last follow-up last follow-up at an average of 2 years after shock wave therapy
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
For arthroscopy:
Ankle pain, aggravated after exercise or weight-bearing activity, accompanied by lameness, joint stiffness and dysfunction for at least 3 months
No talar collapse
Talar cartilage injury cases before stage Ⅳ of Hepple classification
For shock wave therapy:
Patients with micro-fractures treated with arthroscopic treatment of talar cartilage injury and were treated with routine rehabilitation training after arthroscopy
Patients who till complained obvious ankle pain 3 months after surgery
Exclusion Criteria:
Severe cardiovascular and cerebrovascular diseases
Hemorrhagic diseases, coagulation disorders
Bone immaturity
Thrombosis
Use of anti-immune agents
Various types of tumor patients
Pregnant women
History of mental illness
Patients who could not be followed
Patients with other lower extremity injuries after surgery and were unwilling to participate in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xiaojun Duan, M.D.
Organizational Affiliation
Southwest Hospital, China
Official's Role
Principal Investigator
Facility Information:
Facility Name
Southwest Hospital
City
Chongqing
Country
China
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus
We'll reach out to this number within 24 hrs